Company / Cash & Equivalents
Cosmos Health Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$715.7K
FY2025
5-year range
$286.5K / $20.7M
FY2021-FY2025
Trend
+127.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 9 years, ranging from $38,537 in FY2019 to $21M in FY2022.
Based on SEC 10-K filings.
$715,674 in FY2025 with a 5-year CAGR of +2.6%.
Declined from $21M to $715,674 over the past 3 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -67.4%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, cash & equivalents increased 127.1% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
- Lowest cash & equivalents in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $715.7K | +127.1% |
| FY2024 | $315.1K | - |
| FY2023 | - | - |
| FY2022 | $20.7M | +7142.8% |
| FY2021 | $286.5K | -54.4% |
| FY2020 | $628.4K | +1530.6% |
| FY2019 | $38.5K | -95.5% |
| FY2018 | $864.3K | +20.6% |
| FY2017 | $716.6K | +261.8% |
| FY2016 | $198.0K | +0.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026